Add to ORKGBackground: Female injection drug users (IDUs) may report differences in injection behaviours that put them at greater risk for hepatitis C virus (HCV). Few studies have examined these in association with HCV incidence. Methods: Longitudinal data from a c
The aim of this research was to quantify the sero-prevalence of antibody to hepatitis C among inject...
Background: It is increasingly recognized that the risk for HIV and hepatitis C (HCV) transmission a...
Background. In studies of hepatitis C virus (HCV) seroconversion in injection drug users (IDUs), som...
The present study examined reasons for the high incidence of hepatitis C virus (HCV) infection among...
This study from the United States of America provides valuable information on differences in hepatit...
Women who inject drugs have been shown to have higher incidence of HIV and risk behaviours than men,...
Women who inject drugs have been shown to have higher incidence of HIV and risk behaviours than men,...
Objectives. We evaluated risk for hepatitis C virus (HCV) infection in women residing in low-income ...
(See the editorial commentary by Hahn, on pages 1556–9.) Background. Hepatitis C virus (HCV) is the ...
(See the editorial commentary by Hahn, on pages 1556–9.) Background. Hepatitis C virus (HCV) is the ...
Background: The drug using risk behaviors associated with injection drug use are a major public heal...
Background: The drug using risk behaviors associated with injection drug use are a major public heal...
Sharing needles and ancillary injection drug equipment places injection drug users (IDU) at risk for...
Includes bibliographical references (pages 38-43).Hepatitis C is the most common bloodborne infectio...
Sharing needles and ancillary injection drug equipment places injection drug users (IDU) at risk for...
The aim of this research was to quantify the sero-prevalence of antibody to hepatitis C among inject...
Background: It is increasingly recognized that the risk for HIV and hepatitis C (HCV) transmission a...
Background. In studies of hepatitis C virus (HCV) seroconversion in injection drug users (IDUs), som...
The present study examined reasons for the high incidence of hepatitis C virus (HCV) infection among...
This study from the United States of America provides valuable information on differences in hepatit...
Women who inject drugs have been shown to have higher incidence of HIV and risk behaviours than men,...
Women who inject drugs have been shown to have higher incidence of HIV and risk behaviours than men,...
Objectives. We evaluated risk for hepatitis C virus (HCV) infection in women residing in low-income ...
(See the editorial commentary by Hahn, on pages 1556–9.) Background. Hepatitis C virus (HCV) is the ...
(See the editorial commentary by Hahn, on pages 1556–9.) Background. Hepatitis C virus (HCV) is the ...
Background: The drug using risk behaviors associated with injection drug use are a major public heal...
Background: The drug using risk behaviors associated with injection drug use are a major public heal...
Sharing needles and ancillary injection drug equipment places injection drug users (IDU) at risk for...
Includes bibliographical references (pages 38-43).Hepatitis C is the most common bloodborne infectio...
Sharing needles and ancillary injection drug equipment places injection drug users (IDU) at risk for...
The aim of this research was to quantify the sero-prevalence of antibody to hepatitis C among inject...
Background: It is increasingly recognized that the risk for HIV and hepatitis C (HCV) transmission a...
Background. In studies of hepatitis C virus (HCV) seroconversion in injection drug users (IDUs), som...